Latest

10:18
【Guotai CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517400) fell 2.19%, with its scale increasing by RMB 334 million over the past 2 weeks】NewTimeSpace News, as of 10:14 on August 13, 2026, Guotai CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517400) fell 2.19%, with the latest price at RMB 1.61.In terms of size, Guotai CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's scale grew by RMB 334 million over the past 2 weeks, achieving significant growth, with the newly added AUM ranking 3rd out of 6 among comparable funds.In terms of shares outstanding, Guotai CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's shares increased by 99.00 million over the past 2 weeks, achieving significant growth, with the newly added shares ranking 3rd out of 6 among comparable funds.
Tag： ETF517400.SHGuotai CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF
10:13
【Csop Ftse Hk-Korea Tech+ Index Etf (03431.HK) Rises 3.41% in Morning Trade, Turnover Reaches HKD 10.3113 Million】NewTimeSpace News: As of August 13 at 10:10, Csop Ftse Hk-Korea Tech+ Index Etf (03431.HK) rose 3.41%, with a latest price of HKD 10.620.
Tag： 03431.HKETFCsop Ftse Hk-Korea Tech+ Index ETF
10:11
【Fullgoal SSE STAR Chip Index ETF (588810) rose 2.34%, with the latest margin buying amount reaching RMB 6.1777 million】NewTimeSpace News, as of 10:05 on August 13, 2026, Fullgoal SSE STAR Chip Index ETF (588810) rose 2.34%, with the latest price at RMB 2.67.In terms of liquidity, Fullgoal SSE STAR Chip Index ETF recorded an intraday turnover rate of 1.75% with a turnover of RMB 27.5627 million. Over a longer horizon, as of August 12, the ETF's average daily turnover over the past 1 month was RMB 158 million.In terms of size, Fullgoal SSE STAR Chip Index ETF's latest AUM reached RMB 1.538 billion.
Tag： ETF588810.SHFullgoal SSE STAR Chip Index ETF
10:10
【Immunofoco HKEX IPO filing lapses; core CAR-T therapy IMC002 enters pivotal Phase III】NewTimeSpace News: Shenzhen Immunofoco Biotechnology Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; Huatai International acted as the original sole sponsor. Core product IMC002, a potentially best-in-class anti-CLDN18.2 CAR-T cell therapy candidate ranking second globally in clinical progress, is in pivotal Phase III; the global CAR-T cell therapy market is expected to grow from USD 4.7 billion in 2024 to USD 35.2 billion in 2035.
Tag： ImmunofocoIPOIPO application lapsed
10:09
【CSOP KOSPI 200 ETF (03121.HK) Rises 4.35% in Morning Trade, Turnover Reaches HKD 8.7436 Million】NewTimeSpace News: As of August 13 at 10:06, CSOP KOSPI 200 ETF (03121.HK) rose 4.35%, with a latest price of HKD 6.350.
Tag： CSOP KOSPI 200 ETFETF03121.HK
10:05
【ChinaAMC CSI 5G Communication Theme ETF (515050) rose 2.39%, with its scale increasing by RMB 646 million over the past 1 week】NewTimeSpace News, as of 10:00 on August 13, 2026, ChinaAMC CSI 5G Communication Theme ETF (515050) rose 2.39%, with the latest price at RMB 1.07.In terms of size, ChinaAMC CSI 5G Communication Theme ETF's scale grew by RMB 646 million over the past 1 week, achieving significant growth, with the newly added AUM ranking 1st out of 2 among comparable funds.In terms of shares outstanding, ChinaAMC CSI 5G Communication Theme ETF's shares increased by 76.00 million over the past 1 week, achieving significant growth, with the newly added shares ranking 1st out of 2 among comparable funds.
Tag： ETF515050.SHChinaAMC CSI 5G Communication Theme ETF
10:04
【Hai Robotics HKEX IPO filing lapses; global ACR solutions market share exceeds 30%】NewTimeSpace News: Shenzhen Hai Robotics Innovation Intelligent Technology Group Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; Goldman Sachs and CITIC Securities acted as the original joint sponsors. According to CIC, in 2024 the Company was the world's largest provider of ACR (automated case-handling robot) solutions, with a market share of over 30% by revenue and shipment volume, covering more than 40 countries and regions; orders from markets outside mainland China accounted for over 50% for the nine months ended 30 September 2025.
Tag： HAI ROBOTICSIPOIPO application lapsed
10:04
【Ishares Core Msci Taiwan Index Etf (03074.HK) Rises 1.09% in Morning Trade, Turnover Reaches HKD 3.4422 Million】NewTimeSpace News: As of August 13 at 09:58, Ishares Core Msci Taiwan Index Etf (03074.HK) rose 1.09%, with a latest price of HKD 480.200.
Tag： Ishares Core Msci Taiwan Index Etf03074.HKETF
10:00
【Harfor CSI Artificial Industry ETF(515980) rose 2.92%, with the latest margin buying amount reaching RMB 7.3024 million】NewTimeSpace News, as of 09:50 on August 13, 2026, Harfor CSI Artificial Industry ETF (515980) rose 2.92%, with the latest price at RMB 1.09.In terms of liquidity, Harfor CSI Artificial Industry ETF recorded an intraday turnover rate of 1.72% with a turnover of RMB 118 million. Over a longer horizon, as of August 12, the ETF's average daily turnover over the past 1 year was RMB 453 million.In terms of size, Harfor CSI Artificial Industry ETF's latest AUM reached RMB 6.151 billion.
Tag： ETF515980.SHHarfor CSI Artificial Industry ETF
09:59
【Bosera Szse Chinext Daily (2x) Leveraged Product (07234.HK) Rises 2.99% in Morning Trade, Turnover Reaches HKD 2.7314 Million】NewTimeSpace News: As of August 13 at 09:55, Bosera Szse Chinext Daily (2x) Leveraged Product (07234.HK) rose 2.99%, with a latest price of HKD 10.000.
Tag： Bosera Szse Chinext Daily (2x) Leveraged ProductETF07234.HK
09:58
【Nanjing Novlead Biotechnology HKEX filing lapsed; core product iNOwill is world's first electrochemical catalytic iNO therapy device】NewTimeSpace News: Nanjing Novlead Biotechnology Co., Ltd. filed with HKEX on 13 February 2026 with CCB International as sole sponsor, which lapsed after six months. The Company is the world's only enterprise covering a complete product line across NO therapeutic and diagnostic applications; core product iNOwill is the world's first electrochemical catalytic iNO therapy device (No. 1 by market share in China's iNO therapy market in 2024), with 5 approved products and 4 pipeline candidates.
Tag： Novlead BiotechIPO application lapsedIPO
09:33
【WERIDE-W(00800.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 789.75 million, loss narrowed by 0.22% YoY】NewTimeSpace News: August 12, 2026, WERIDE-W(00800.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 345.86 million, increased by 73.26% YoY.
Tag： WERIDE-W00800.HKloss narrowed
09:32
【Alpha Pro Holdings (00948.HK) Proposes Rights Issue on the Basis of 1 Rights Share for Every 1 Existing Share, to Raise Net Proceeds of Approximately HK$81 Million】NewTimeSpace News: ALPHA PRO HLDGS (00948.HK) plans to conduct a rights issue on the basis of "1 for 1", with estimated net proceeds of HKD 81 million.
Tag： ALPHA PRO HLDGS00948.HKH-share placement
09:30
【YUE YUEN IND(00551.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 72 million, YoY decrease of 57.94%】NewTimeSpace News: August 12, 2026, YUE YUEN IND(00551.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 3.97 billion, decreased by 2.16% YoY.
Tag： YUE YUEN IND00551.HKProfit declined
09:28
【NEXTEER(01316.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 85.81 million, YoY increase of 35.17%】NewTimeSpace News: August 12, 2026, NEXTEER(01316.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 2.33 billion, increased by 3.86% YoY.
Tag： NEXTEER01316.HKprofit growth
09:27
【CIRCUTECH(08051.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 4.97 million, YoY increase of 15.61%】NewTimeSpace News: August 12, 2026, CIRCUTECH(08051.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 229.35 million, increased by 4.77% YoY.
Tag： CIRCUTECH08051.HKprofit growth
09:26
【BLOKS(00325.HK)2026 Interim Report - Profit Attributable to Shareholders stood at CNY 387.08 million, YoY increase of 30.55%】NewTimeSpace (newtimespace.com) News, August 12, 2026, BLOKS(00325.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.78 billion, increased by 32.71% YoY
Tag： BLOKS00325.HKNewTimeSpace
09:25
【K W NELSON GP(08411.HK)2026 Interim Report - Profit Attributable to Shareholders stood at HKD 2.44 million, turned profitable from a loss YoY】NewTimeSpace (newtimespace.com) News, August 12, 2026, K W NELSON GP(08411.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 20.48 million, increased by 66.97% YoY
Tag： K W NELSON GP08411.HKNewTimeSpace
09:25
【ZELGEN (688266.SH): Files second HKEX listing application with CICC as sole sponsor; H1 net profit of RMB 640 million】NewTimeSpace News: On 12 August 2026, ZELGEN (688266.SH) filed its second listing application with HKEX, with CICC as sole sponsor. The Company has four marketed drugs and 10 candidates across 29 major clinical programmes, with ZG006 being the world's first DLL3/DLL3/CD3 trispecific antibody. Financially, the Company recorded aggregate net losses of approximately RMB 611 million in 2023-2025 and turned to a net profit of RMB 640 million in H1 2026 driven by the AbbVie upfront payment, while cautioning that the profitability may not be sustainable in the near term.
Tag： ZELGEN688266.SHIPOA+Hfile a listing application
09:23
【ZERO2IPO(01945.HK)2026 Interim Report - Profit Attributable to Shareholders stood at CNY 15.1 million, turned profitable from a loss YoY】NewTimeSpace (newtimespace.com) News, August 12, 2026, ZERO2IPO(01945.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 71.03 million, increased by 27.24% YoY
Tag： ZERO2IPO01945.HKNewTimeSpace
Previous1..8788 899091..488     488 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments